Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Planned sale CEO sold 50,000 shares at an average $23.77 ($1,188,745)
  2. 4 Planned sale SVP, Finance and Treasurer sold 187 shares at $24.41 ($4,565)
  3. 4 Gift President gave 123,407 shares (gift)
  4. 4 Planned sale Chief Medical Officer sold 16,667 shares at $25.74 ($429,037)
  5. 4 Planned sale Chief Medical Officer sold 373 shares at $34.73 ($12,954)
  6. 4 Planned sale CEO sold 50,000 shares at an average $34.90 ($1,745,037)
  7. 4 Open-market sale 10% owner sold 284,860 shares at an average $35.24 ($10,039,492)
  8. 4 Option exercise President acquired 35,505 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Planned sale CEO sold 30,078 shares at $24.58 ($739,317)
  16. 4 Planned sale Chief Medical Officer sold 6,700 shares at $24.58 ($164,686)
  17. 4 Planned sale SVP, Finance and Treasurer sold 3,242 shares at $24.58 ($79,688)
  18. 4 Planned sale Chief Legal Officer sold 5,956 shares at $24.58 ($146,398)
  19. 4 Planned sale President sold 11,810 shares at $24.58 ($290,290)
  20. 4 Grant or award Chief Legal Officer acquired 20,000 shares (grant or award)

Page 1 of 12 · 238 filings